Evolution of characteristics of MASLD with and without diabetes: A meta- analysis of placebo arms
Abstract Background: We explored the changes in metabolic dysfunction-associated steatotic liver disease (MASLD) severity over time by analyzing data from the placebo arms of randomized controlled trials (RCTs), particularly in relation to the presence of diabetes. Methods: RCTs on MASLD that included a placebo arm were identified using a systematic search of the literature. The primary outcomes were the changes in hepatic steatosis and fibrosis. Results: The meta-analysis included 8 RCTs involving 386 patients without diabetes and 24 RCTs involving 637 patients with diabetes. The pooled estimate of mean change in steatosis grade by histology was -0.1 in patients without diabetes, and -0.37 in patients with diabetes (P=0.066). The mean change in fibrosis stage by histology was 0.05 in patients without diabetes, and -0.03 in patients with diabetes (P=0.359). The mean change in nonalcoholic fatty liver disease activity score was -0.55 in patients without diabetes, and -1.50 in patients with diabetes (P=0.100).The mean change in ALT (-20.22 IU/L vs. -4.48 IU/L) and AST (-10.67 IU/L vs. -2.58 IU/L) were significantly larger in patients without diabetes compared to those with diabetes (P <0.05). Conclusion: In the placebo arm, patients with diabetes showed greater improvement in liver steatosis than those without diabetes..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
ResearchSquare.com - (2024) vom: 30. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lee, Han Ah [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.21203/rs.3.rs-3847827/v1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XRA042340284 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | XRA042340284 | ||
| 003 | DE-627 | ||
| 005 | 20240131145846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240131s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21203/rs.3.rs-3847827/v1 |2 doi | |
| 035 | |a (DE-627)XRA042340284 | ||
| 035 | |a (ResearchSquare)10.21203/rs.3.rs-3847827/v1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lee, Han Ah |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evolution of characteristics of MASLD with and without diabetes: A meta- analysis of placebo arms |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background: We explored the changes in metabolic dysfunction-associated steatotic liver disease (MASLD) severity over time by analyzing data from the placebo arms of randomized controlled trials (RCTs), particularly in relation to the presence of diabetes. Methods: RCTs on MASLD that included a placebo arm were identified using a systematic search of the literature. The primary outcomes were the changes in hepatic steatosis and fibrosis. Results: The meta-analysis included 8 RCTs involving 386 patients without diabetes and 24 RCTs involving 637 patients with diabetes. The pooled estimate of mean change in steatosis grade by histology was -0.1 in patients without diabetes, and -0.37 in patients with diabetes (P=0.066). The mean change in fibrosis stage by histology was 0.05 in patients without diabetes, and -0.03 in patients with diabetes (P=0.359). The mean change in nonalcoholic fatty liver disease activity score was -0.55 in patients without diabetes, and -1.50 in patients with diabetes (P=0.100).The mean change in ALT (-20.22 IU/L vs. -4.48 IU/L) and AST (-10.67 IU/L vs. -2.58 IU/L) were significantly larger in patients without diabetes compared to those with diabetes (P <0.05). Conclusion: In the placebo arm, patients with diabetes showed greater improvement in liver steatosis than those without diabetes. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Lee, Hye Ah |4 aut | |
| 700 | 1 | |a Kim, Hwi Young |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2024) vom: 30. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:30 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-3847827/v1 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XRA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 30 |c 01 | ||